Abstract
Livedoid vasculopathy (LV) is an occlusive thrombotic disease of lower extremities. A 34-year-old woman presented with 4-year history of recurrent necrotic and painful lesions with violaceous and purpuric border on both legs. Initial treatment with hydroxychloroquine, dapsone and prednisone were unsuccessful. Skin biopsy showed inflammatory infiltrate with epidermal necrosis. Prothrombin G20210A and factor V-Leiden heterozygosity, and MTHFR C677T homozygosity with hyperhomocysteinemia were confirmed. LV diagnosis was made; acetylsalicylic acid, folic acid, vitamin B12, and prednisone treatement resulted in complete healing. This is the first report on coexistence of prothrombin G20210A, factor V-Leiden, and homozygous MTHFR C677T with hyperhomocysteinemia in LV.
Similar content being viewed by others
References
Schroeter AL, Diaz Perez JL, Winkelmann RK (1975) Livedo vasculitis (the vasculitis of atrophie blanche): immunohistopathologic study. Arch Dermatol 111:188–193
Marzano AV, Vanotti M, Alessi E (2003) Widespread livedoid vasculopathy. Acta Derm Venereol 83:457–460
Bard JW, Winkelmann RK (1967) Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol 96:489–499
Jorizzo JL (1998) Livedoid vasculopathy: what is it? Arch Dermatol 134:491–493
Mimouni D, Ng PP, Rencic A et al (2003) Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 148:789–794
Maessen-Visch MB, Koedam MI, Hamulyák K, Neumann HA (1999) Atrophie blanche. Int J Dermatol 38:161–172
Hairston BR, Davis MD, Pittelkow MR, Ahmed I (2006) Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 142:1413–1418
Biedermann T, Flaig MJ, Sander CA (2000) Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol 27:410–412
Calamia KT, Balabanova M, Perniciaro C, Walsh JS (2002) Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol 46:133–137
Anavekar NS, Kelly R (2007) Heterozygous prothrombin gene mutation associated with livedoid vasculopathy. Australas J Dermatol 48:120–123
Gibson GE, Li H, Pittelkow MR (1999) Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol 40:279–281
Cardoso R, Goncalo M, Tellechea O et al (2007) Livedoid vasculopathy and hypercoagulability in a patient with primary Sjogren’s syndrome. Int J Dermatol 46:431–434
Deng A, Gocke CD, Hess J et al (2006) Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 142:1466–1469
Boyvat A, Kundakçi N, Babikir MO, Gürgey E (2000) Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 143:840–842
Meiss F, Marsch WC, Fischer M (2006) Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol 16:159–162
Acland KM, Darvay A, Wakelin SH, Russell-Jones R (1999) Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 140:131–135
Grasland A, Crickx B, Blanc M, Pouchot J, Vinceneux P (2000) Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies. Ann Med Interne (Paris) 151:408–410
Papi M, Didona B, De Pita O et al (1998) Livedo vasculopathy vs. small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol 134:447–452
Browning CE, Callen JP (2006) Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 142:75–78
Lewerenz V, Burchardt T, Büchau A, Ruzicka T, Megahed M (2004) Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome. Hautarzt 55:379–381
Hairston BR, Davis MD, Gibson LE, Drage LA (2003) Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 139:987–990
Klein KL, Pittelkow MR (1992) Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 67:923–933
Pitarch G, Rodriguez-Serna M, Torrijos A, Oliver V, Fortea JM (2005) Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins. Acta Derm Venereol 85:374–375
Magy N, Algros MP, Racadot E et al (2002) Liveoid vasculopathy with combined thrombophilia: efficacy of iloprost. Rev Med Interne 23:554–557
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Irani-Hakime, N.A., Stephan, F., Kreidy, R. et al. Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity. J Thromb Thrombolysis 26, 31–34 (2008). https://doi.org/10.1007/s11239-008-0214-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-008-0214-1